Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Gel for Post-Haemorrhoidectomy Pain
NCT06420388Recruiting
- Sponsor
- E-Da Hospital
- Start
- May 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in postoperative pain (2 arms), sponsored by E-Da Hospital. Primary endpoint: Postoperative pain intensity assessed by Visual Analog Scale at 7 days. Started May 2023; status: recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06420388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06420388.